M&A activity in the healthcare sector declined in the second quarter of 2023, reaching its lowest point in three years. This decrease suggests a slowdown in dealmaking within the industry.
Lower valuations and divestitures of non-core assets in healthcare companies are expected to drive an increase in M&A activity in the second half of the year. Buyers who were previously deterred by high valuations may find deals more attractive now.
The trend of clinical services moving from hospitals to ambulatory surgery centers (ASCs) and doctor's offices continues to impact healthcare dealmaking. Regions with a significant shift in medical procedures to ASCs and offices, such as Austin and Las Vegas, could present attractive opportunities for buyers.
Lower valuations and divestitures of non-core assets in healthcare companies are expected to drive an increase in M&A activity in the second half of the year. Buyers who were previously deterred by high valuations may find deals more attractive now.
The trend of clinical services moving from hospitals to ambulatory surgery centers (ASCs) and doctor's offices continues to impact healthcare dealmaking. Regions with a significant shift in medical procedures to ASCs and offices, such as Austin and Las Vegas, could present attractive opportunities for buyers.
[
add
]
[
|
|
...
]